Press Releases
-
CD Genomics Fully Supports Your Microbiome Research with Comprehensive Sequencing Solutions
-
CD Formulation Optimizes Elemental Impurities Analysis Service
-
Biotium Introduces Unique Super-Sensitive RNA Prestain Loading Dye
Biotium has announced the release of EMBER500™ RNA Prestain Loading Dye.
Jan 4, 2022
-
Emmes Acquires Institut Dr. Schauerte
-
WuXi STA Passes the First U.S. FDA Drug Product Pre-Approval Inspection at its Shanghai Waigaoqiao site
-
WuXi STA Forms Strategic Partnership with Coherent Biopharma
-
Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19
-
Sensyne Health and Cambridge University Hospitals NHS Foundation Trust Sign Strategic Research Agreement
Research will focus on CUH’s areas of disease expertise and specialism in cancer, cardiovascular disease and rare diseases New agreement covers 3 million patient records and brings the combined total of de-identified patient data directly accessible for medical research to 25.5 million patients
Dec 2, 2021
-
DFE Pharma researcher recognized as one of the 2021 Outstanding Early Career Scientists
-
CluePoints Wins Scrip Award for Clinical Advance of the Year 2021
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category - COVID-19 Pandemic Special Recognition Award at the 17th Annual Scrip Awards.
Dec 5, 2021
-
Global pharma industry gathers at CPhI Worldwide 2021 as surge in partnering expected in 2022
Over 25,000 online and 23,000 in person attendees at the world’s largest pharma trade exhibition
Nov 24, 2021
-
BaseClear announces the appointment of Dr. Alex van Belkum as Chief Scientific Officer (CSO), effective December 1, 2021
BaseClear has announced the appointment of Dr. Alex Van Belkum as Chief Scientific Officer (CSO).
Nov 28, 2021
-
ProRelix Research LLC starts clinical trial operations in USA to conduct multi country clinical trials
-
Tower launches “game-changing” solution for the transport of ultra cold temperature-critical pharmaceuticals
Tower launches “game-changing” solution for the transport of ultra cold temperature-critical pharmaceuticals
Nov 29, 2021
-
Curebase’s Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study
Curebase’s Enhanced Telemedicine Feature Expands Patient Access to Edesa Biotech Derm Study
Nov 29, 2021
-
VIDA Diagnostics to Address Overcoming Pervasive Challenges in Respiratory Clinical Trials During 12/8 Webinar
A 12/8 webinar with leading pulmonary disease clinician Dr. Mario Castro will address the rise of imaging in respiratory clinical trials, something worth hearing considering the uncertainty of the long-term impact of COVID-19 and other factors.
Nov 30, 2021
-
Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research
Australian clinical-stage drug development company Noxopharm (ASX:NOX) has in-licensed novel RNA technology developed by Hudson Institute of Medical Research. The exclusive global contract aims to maximize opportunities in RNA drug discovery and mRNA vaccine manufacture through Noxopharm’s wholly owned subsidiary, Pharmorage.
Nov 30, 2021
-
Formedix Launches Community Forum and Resource Hub to Support Clinical Trial Industry
Formedix has announced the launch of a community forum and resource hub to allow contract research organizations and pharmaceutical companies using the ryze clinical metadata repository.
Nov 30, 2021
-
BOC Sciences Adds Phosphoramidites to Its Nucleotide Product Portfolio for Oligonucleotide Synthesis
-
T,C&A Lab Offers Glass Testing to Reduce Risk and Validate Glass Performance